Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.062 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |